These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29578503)

  • 1. Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster.
    Donnelly KM; Pearce MMP
    J Vis Exp; 2018 Mar; (133):. PubMed ID: 29578503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the spreading and toxicity of prion-like proteins using the metazoan model organism C. elegans.
    Nussbaum-Krammer CI; Neto MF; Brielmann RM; Pedersen JS; Morimoto RI
    J Vis Exp; 2015 Jan; (95):52321. PubMed ID: 25591151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain.
    Pearce MMP; Spartz EJ; Hong W; Luo L; Kopito RR
    Nat Commun; 2015 Apr; 6():6768. PubMed ID: 25866135
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sandhof CA; Hoppe SO; Tittelmeier J; Nussbaum-Krammer C
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32824215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prions on the run: How extracellular vesicles serve as delivery vehicles for self-templating protein aggregates.
    Liu S; Hossinger A; Göbbels S; Vorberg IM
    Prion; 2017 Mar; 11(2):98-112. PubMed ID: 28402718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion-Like Characteristics of Polyglutamine-Containing Proteins.
    Pearce MMP; Kopito RR
    Cold Spring Harb Perspect Med; 2018 Feb; 8(2):. PubMed ID: 28096245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Prions in the Brain.
    Rayman JB; Kandel ER
    Cold Spring Harb Perspect Biol; 2017 Jan; 9(1):. PubMed ID: 28049644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models for prion-like diseases.
    Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
    Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting prion-like protein spreading in neurodegenerative diseases.
    Zhang Z; Nie S; Chen L
    Neural Regen Res; 2018 Nov; 13(11):1875-1878. PubMed ID: 30233055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcellular spreading of huntingtin aggregates in the Drosophila brain.
    Babcock DT; Ganetzky B
    Proc Natl Acad Sci U S A; 2015 Sep; 112(39):E5427-33. PubMed ID: 26351672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hunting for the cause: Evidence for prion-like mechanisms in Huntington's disease.
    Donnelly KM; Coleman CM; Fuller ML; Reed VL; Smerina D; Tomlinson DS; Pearce MMP
    Front Neurosci; 2022; 16():946822. PubMed ID: 36090278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.
    Yoshida S; Hasegawa T
    Neurochem Int; 2022 May; 155():105307. PubMed ID: 35181393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis.
    Ekhtiari Bidhendi E; Bergh J; Zetterström P; Forsberg K; Pakkenberg B; Andersen PM; Marklund SL; Brännström T
    Acta Neuropathol; 2018 Dec; 136(6):939-953. PubMed ID: 30284034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
    van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
    BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis.
    Grad LI; Fernando SM; Cashman NR
    Neurobiol Dis; 2015 May; 77():257-65. PubMed ID: 25701498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prions and prion-like pathogens in neurodegenerative disorders.
    Peggion C; Sorgato MC; Bertoli A
    Pathogens; 2014 Feb; 3(1):149-63. PubMed ID: 25437612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases.
    Xiang L; Wang Y; Liu S; Liu B; Jin X; Cao X
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.